|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 17/09/14 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 04/09/14 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 01/04/2002 | |
Carla Fiankan
LAW | General Counsel | - | 01/08/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.73% | -1.59% | -1.63% | +10.89% | 46.86B | ||
| +0.25% | +1.65% | +399.22% | +647.65% | 40.23B | ||
| -0.27% | +4.45% | +11.81% | +60.81% | 36.23B | ||
| +0.35% | +0.87% | +4.46% | -10.31% | 34.72B | ||
| +3.14% | +1.02% | +4.76% | +43.00% | 27.89B | ||
| -0.73% | +11.84% | +34.39% | +134.44% | 16.79B | ||
| +0.47% | -2.74% | - | - | 16.74B | ||
| +1.08% | -5.60% | +2.60% | +8.08% | 13.12B | ||
| -2.68% | -2.49% | -11.36% | -34.51% | 12.7B | ||
| Average | +0.37% | +0.83% | +55.53% | +107.51% | 27.25B | |
| Weighted average by Cap. | +0.63% | +0.91% | +75.12% | +137.98% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















